Impaired glucose tolerance in pregnant women with polycystic ovary syndrome

被引:99
作者
Radon, PA [1 ]
McMahon, MJ [1 ]
Meyer, WR [1 ]
机构
[1] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1016/S0029-7844(99)00252-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether women with polycystic ovary syndrome (PCOS) are more likely to develop gestational diabetes mellitus compared with age- and weight-matched controls. Methods: This retrospective cohort study compared reproductive-age women with and without PCOS who received prenatal care at the University of North Carolina Hospitals between April 1989 and June 1998. Fie reviewed the medical charts of 22 women with PCOS diagnosis before pregnancy based on menstrual histories, elevated androgen levels, and LH-FSH ratios greater than 2. These women were compared with 66 women without PCOS matched for age and weight. Gestational diabetes mellitus (GDM) was diagnosed in women if they had abnormal results on a 50-g glucose screening test and at least two abnormal plasma glucose values during a 100-g glucose tolerance test. Medical complications of pregnancy, pregnancy complications, and birth outcomes were compared between women with and without PCOS. Results: Nine of 22 women with PCOS also had GDM diagnosis, compared with two of 66 controls (odds ratio [OR] 22.2; 95% confidence interval [CI] 3.8, 170.0), and these women exhibited increased plasma glucose values for all measurements except fasting. Five of 22 women with PCOS developed preeclampsia compared with one of 66 controls (OR 15.0; 95% CI 1.9, 121.5). Conclusion: Women with PCOS are at increased risk of glucose intolerance and preeclampsia during pregnancy. (C) 1999 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:194 / 197
页数:4
相关论文
共 19 条
[1]  
[Anonymous], 1992, POLYCYSTIC OVARY SYN
[2]   Polycystic ovaries in women with gestational diabetes [J].
Anttila, L ;
Karjala, K ;
Penttilä, TA ;
Ruutiainen, K ;
Ekblad, U .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (01) :13-16
[3]   INSULIN RESISTANCE IN NON-OBESE PATIENTS WITH POLYCYSTIC OVARIAN DISEASE [J].
CHANG, RJ ;
NAKAMURA, RM ;
JUDD, HL ;
KAPLAN, SA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (02) :356-359
[4]  
DAHLGREN E, 1992, FERTIL STERIL, V57, P505
[5]   CLINICAL AND BIOLOGICAL PHENOTYPES IN LATE-ONSET 21-HYDROXYLASE DEFICIENCY [J].
DEWAILLY, D ;
VANTYGHEMHAUDIQUET, MC ;
SAINSARD, C ;
BUVAT, J ;
CAPPOEN, JP ;
ARDAENS, K ;
RACADOT, A ;
LEFEBVRE, J ;
FOSSATI, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (02) :418-423
[6]   New perspectives in polycystic ovary syndrome [J].
DiamantiKandarakis, E ;
Dunaif, A .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1996, 7 (08) :267-271
[7]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174
[8]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[9]   Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Schneider, DJ ;
Sobel, BE ;
Cavaghan, MK ;
Imperial, J ;
Rosenfield, RL ;
Polonsky, KS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2108-2116
[10]   GESTATIONAL DIABETES-MELLITUS - A SURVEY OF PERINATAL COMPLICATIONS IN THE 1980S [J].
HOD, M ;
MERLOB, P ;
FRIEDMAN, S ;
SCHOENFELD, A ;
OVADIA, J .
DIABETES, 1991, 40 :74-78